Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally

Nov.06
KT&G Q3 Net Profit Up 73%; Overseas NGP Revenue Nearly Doubles, Nicotine Pouch Expansion Set to Launch Globally
KT&G reported its Q3 2025 financial results, posting revenue of KRW 1.83 trillion (≈USD 1.31 billion) and a 73.4% year-over-year surge in net profit—marking the company’s highest operating profit in five years. The Next Generation Product (NGP) segment performed strongly, generating KRW 279.1 billion (≈USD 199 million) in revenue, with overseas NGP sales more than doubling year-over-year.

2Firsts, November 6, 2025 — Korean tobacco giant KT&G released its financial results for the third quarter of 2025, reporting significant growth across key performance indicators and achieving its highest operating profit in five years.

 

Key Financial Highlights

 

  • Revenue: KRW 1.83 trillion (≈USD 1.31 billion), up 11.6% year-over-year
  • Operating Profit: KRW 465.3 billion (≈USD 332 million), up 11.4%, marking a five-year high
  • Net Profit: KRW 418.7 billion (≈USD 299 million), up 73.4% year-over-year
  • Earnings per Share (EPS): KRW 3,898 (≈USD 2.78)

 

Next Generation Product (NGP) Performance

 

Growth in the NGP segment was driven by expanded device and consumable product lines in both domestic and overseas markets, as well as the fulfillment of backlogged device orders from the first half of the year.

 

  • Total NGP Revenue: KRW 279.1 billion (≈USD 199 million), up from KRW 193.2 billion (≈USD 138 million) in Q3 2024
  • Overseas NGP Revenue: KRW 110.8 billion (≈USD 79 million), up from KRW 36.6 billion (≈USD 26 million) in Q3 2024
  • Domestic NGP Revenue: KRW 168.3 billion (≈USD 120 million)
  • Sales Drivers: The launch of the upgraded lil SOLID device in Russia and the resumption of delayed shipments led to a 13.3% year-over-year increase in consumable sales.

 

Strategic Partnership & Nicotine Pouch Expansion

 

  • Strategic Partnership: KT&G announced a partnership with Altria to jointly acquire Nordic nicotine pouch manufacturer ASF.
  • Global Expansion Plan: Starting in 2026, KT&G aims to expand its nicotine pouch business from five Nordic markets to Europe, the Middle East, Africa, Asia, and North America.
Also Read:
[1] From Partnership to Acquisition: Why KT&G Is Betting on the Global Nicotine Pouch Market
[2] Hanwha Securities: KT&G's Global Market Share Expected to Hit New High, Overseas Heated Tobacco Sales Projected to Grow 74%
[3] South Korean convenience store GS25 and KT&G jointly released a new heated tobacco product, which will be available starting in October
[4] KT&G launches the LIL AIBLE 2.0 PLUS heated tobacco device, featuring fast charging and a new "REAL RIMO" cartridge
COP11 Concludes with Major Decisions on Global Tobacco Control
COP11 Concludes with Major Decisions on Global Tobacco Control
The Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on November 22, with 160 Parties adopting major decisions on tobacco and nicotine regulation, environmental protection, sustainable financing, and tobacco industry liability. A landmark decision mandates a complete ban on the use and sale of tobacco and all novel nicotine products across all UN premises worldwide.
Nov.24 by 2FIRSTS.ai
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL's regulatory journey from Marketing Denial Order to approval showcases FDA's evolving approach to e-cigarette oversight.
Nov.03 by 2FIRSTS.ai
EU Cardiovascular Health Plan Consultation Highlights Tobacco Debate — 2Firsts Analysis Reveals Divide Between “Cessation” and “Harm Reduction” Approaches
EU Cardiovascular Health Plan Consultation Highlights Tobacco Debate — 2Firsts Analysis Reveals Divide Between “Cessation” and “Harm Reduction” Approaches
As the EU finalizes its Cardiovascular Health Plan, public feedback reveals a sharp divide over nicotine policy.A 2Firsts analysis of 677 submissions found that nearly one in four mentioned tobacco — highlighting tension between strict control and harm reduction approaches.
Oct.07
Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade
Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade
California-based vape manufacturer Schwartz E-Liquid (USA Vape Lab) has sued the U.S. Food and Drug Administration (FDA) in federal court, alleging the agency unlawfully failed to issue a decision on its premarket application for flavored e-cigarette products for more than five years. The company is seeking a court order compelling the FDA to act within 90 days.
Nov.26 by 2FIRSTS.ai
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
As the UK prepares to introduce its first-ever vape tax in 2026, questions are growing about how the measure will reshape the country’s harm reduction landscape. IBVTA tells 2Firsts that while it was not in favour of the new duty, it accepts that it is being implemented and is working with regulators to ensure a smooth rollout — warning, however, that higher costs could slow smokers’ transition to safer alternatives.
Oct.07
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. Customs and Border Protection (CBP) seized approximately 165,000 illicit vaping products—including 90,000 e-cigarette devices and 75,000 refill cartridges—valued at over $1.47 million (MSRP). Following a joint assessment with the U.S. Food and Drug Administration (FDA), the products were deemed “adulterated and misbranded” for lacking required premarket authorization and were seized in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act). The shipments, which featured multipl
Sep.30 by 2FIRSTS.ai
Related Topics
Company
Related Read
COP11 Concludes with Major Decisions on Global Tobacco Control
COP11 Concludes with Major Decisions on Global Tobacco Control
2FIRSTS.ai
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL wins approval after FDA reversal of Marketing Denial Order
2FIRSTS.ai
EU Cardiovascular Health Plan Consultation Highlights Tobacco Debate — 2Firsts Analysis Reveals Divide Between “Cessation” and “Harm Reduction” Approaches
EU Cardiovascular Health Plan Consultation Highlights Tobacco Debate — 2Firsts Analysis Reveals Divide Between “Cessation” and “Harm Reduction” Approaches
Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade
Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade
2FIRSTS.ai
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
U.S. CBP and FDA Seize 165,000 Illicit E-Cigarette Products; Total Value Exceeds $1.47 Million
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文